Tag archive

remdesivir

June 15, 2020

FDA Warns of Newly Discovered Potential Drug Interaction That May Reduce COVID-19 Effectiveness of Remdesivir

The FDA is revising the fact sheet for health care providers that accompanies the drug to state that co-administration of remdesivir and chloroquine phosphate or hydroxychloroquine sulfate is not recommended. Keep Reading

May 1, 2020

FDA Issues Emergency Use Authorization for Remdesivir as Potential COVID-19 Treatment

The emergency use authorization allows for remdesivir to be distributed in the U.S. and administered intravenously by health care providers, as appropriate, to treat suspected or laboratory-confirmed COVID-19 in adults and children hospitalized with severe disease. Keep Reading

Go to Top